Evidence map›Paper›PMID 36949940›Full record

ArticleFrontiers in immunology2023

Editorial: Adaptive immunity to respiratory pathogens.

Naoki Iwanaga, Priyadharshini Devarajan, Anukul T Shenoy

Full text readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Naoki IwanagaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Priyadharshini DevarajanDepartment of Pathology, University of Massachusetts Chan Medical School, Worcester, MA, United States.
Anukul T ShenoyPulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.

Funding

Age-Associated B Cells Specialized for Immunity to Pathogens?R21AG068313 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2021 to 2022
$461k
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza VirusR21AI153120 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2020 to 2021
$461k
Lung epithelial cell reprogramming by CD4 T cellsK99HL157555 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SHENOY, ANUKUL T · 2022 to 2023
$271k
NHLBI NIH HHS K99 HL157555NIAID NIH HHS R21 AI153120NIA NIH HHS R21 AG068313
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptive ImmunityCOVID-19Humansadaptive immunityaginglung immunitylung microenvironmentrespiratory infectionSARS – CoV – 2tissue resident immune cellsvaccines

Identifiers

PMID36949940
PMCPMC10026996

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.